Survival analysis applied to sensory shelf life of foods G Hough, K Langohr, G Gómez, A Curia Journal of Food Science 68 (1), 359-362, 2003 | 289 | 2003 |
Left-truncated data with age as time scale: an alternative for survival analysis in the elderly population R Lamarca, J Alonso, G Gomez, Á Muñoz The Journals of Gerontology Series A: Biological Sciences and Medical …, 1998 | 233 | 1998 |
High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study A Bonjoch, M Figueras, C Estany, N Perez-Alvarez, J Rosales, L del Rio, ... Aids 24 (18), 2827-2833, 2010 | 216 | 2010 |
Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence CR Fumaz, JA Munoz-Moreno, J Moltó, E Negredo, MJ Ferrer, G Sirera, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 38 (5), 560-565, 2005 | 209 | 2005 |
Definition of the viral targets of protective HIV-1-specific T cell responses B Mothe, A Llano, J Ibarrondo, M Daniels, C Miranda, J Zamarreño, ... Journal of translational medicine 9, 1-20, 2011 | 188 | 2011 |
Tutorial on methods for interval-censored data and their implementation in R G Gómez, ML Calle, R Oller, K Langohr Statistical Modelling 9 (4), 259-297, 2009 | 168 | 2009 |
Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients JA Muñoz-Moreno, CR Fumaz, MJ Ferrer, A Prats, E Negredo, M Garolera, ... AIDS research and human retroviruses 24 (10), 1301-1307, 2008 | 140 | 2008 |
Sensory shelf-life predictions by survival analysis accelerated storage models G Hough, L Garitta, G Gómez Food quality and Preference 17 (6), 468-473, 2006 | 133 | 2006 |
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients L Ruiz, R Paredes, G Gómez, J Romeu, P Domingo, N Pérez-Alvarez, ... Aids 21 (2), 169-178, 2007 | 107 | 2007 |
Inference for a linear regression model with an interval‐censored covariate G Gómez, A Espinal, S W. Lagakos Statistics in medicine 22 (3), 409-425, 2003 | 87 | 2003 |
Estimation of the infection time and latency distribution of AIDS with doubly censored data G Gómez, SW Lagakos Biometrics, 204-212, 1994 | 79 | 1994 |
HIVconsv vaccines and romidepsin in early-treated HIV-1-infected individuals: safety, immunogenicity and effect on the viral reservoir (Study BCN02) B Mothe, M Rosás-Umbert, P Coll, C Manzardo, MC Puertas, ... Frontiers in immunology 11, 823, 2020 | 78 | 2020 |
Frequentist and Bayesian approaches for interval-censored data G Gomez, ML Calle, R Oller Statistical Papers 45, 139-173, 2004 | 73 | 2004 |
Interval censoring: model characterizations for the validity of the simplified likelihood R Oller, G Gómez, ML Calle Canadian Journal of Statistics 32 (3), 315-326, 2004 | 68 | 2004 |
Statistical considerations when using a composite endpoint for comparing treatment groups G Gómez, SW Lagakos Statistics in Medicine 32 (5), 719-738, 2013 | 59 | 2013 |
Análisis de supervivencia MJR López, JL Fidalgo La Muralla, 2000 | 58 | 2000 |
Using the STROBE statement: survey findings emphasized the role of journals in enforcing reporting guidelines MK Sharp, L Bertizzolo, R Rius, E Wager, G Gómez, D Hren Journal of clinical epidemiology 116, 26-35, 2019 | 55 | 2019 |
Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs CR Fumaz, JA Muñoz-Moreno, J Molto, MJ Ferrer, R López-Blázquez, ... AIDS care 20 (7), 796-805, 2008 | 51 | 2008 |
A cross-sectional bibliometric study showed suboptimal journal endorsement rates of STROBE and its extensions MK Sharp, R Tokalić, G Gómez, E Wager, DG Altman, D Hren Journal of clinical epidemiology 107, 42-50, 2019 | 45 | 2019 |
Informed choice of composite end points in cardiovascular trials G Gomez, M Gomez-Mateu, U Dafni Circulation: Cardiovascular Quality and Outcomes 7 (1), 170-178, 2014 | 44 | 2014 |